Epidemiology and Etiology of Severe Childhood Encephalitis in The Netherlands.
Child
Child, Preschool
Encephalitis
/ epidemiology
Encephalitis, Viral
/ diagnosis
Female
Hospitalization
/ statistics & numerical data
Humans
Infant
Infectious Encephalitis
/ diagnosis
Intensive Care Units, Pediatric
/ statistics & numerical data
Male
Netherlands
/ epidemiology
Retrospective Studies
Severity of Illness Index
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
pubmed:
26
2
2020
medline:
10
2
2021
entrez:
26
2
2020
Statut:
ppublish
Résumé
Limited data are available on childhood encephalitis. Our study aimed to increase insight on clinical presentation, etiology, and clinical outcome of children with severe encephalitis in the Netherlands. We identified patients through the Dutch Pediatric Intensive Care Evaluation database and included children diagnosed with encephalitis <18 years of age admitted to 1 of the 8 pediatric intensive care units (PICU) in the Netherlands between January 2003 and December 2013. We analyzed demographic characteristics, clinical symptoms, neurologic imaging, etiology, treatment and mortality. We included 121 children with a median age of 4.6 years (IQR 1.3-9.8). The most frequently described clinical features were headache (82.1%), decreased consciousness (79.8%) and seizures (69.8%). In 44.6% of the children, no causative agent was identified. Viral- and immune-mediated encephalitis were diagnosed in 33.1% and 10.7% of the patients. A herpes simplex virus infection (13.2%) was mainly seen in children <5 years of age, median age, 1.73 years (IQR 0.77-5.01), while immune-mediated encephalitis mostly affected older children, median age of 10.4 years (IQR, 3.72-14.18). An age of ≥ 5 years at initial presentation was associated with a lower mortality (OR 0.2 [CI 0.08-0.78]). The detection of a bacterial (OR 9.4 [CI 2.18-40.46]) or viral (OR 3.7 [CI 1.16-11.73]) pathogen was associated with a higher mortality. In almost half of the Dutch children presenting with severe encephalitis, a causative pathogen could not be identified, underlining the need for enhancement of microbiologic diagnostics. The detection of a bacterial or viral pathogen was associated with a higher mortality.
Sections du résumé
BACKGROUND
Limited data are available on childhood encephalitis. Our study aimed to increase insight on clinical presentation, etiology, and clinical outcome of children with severe encephalitis in the Netherlands.
METHODS
We identified patients through the Dutch Pediatric Intensive Care Evaluation database and included children diagnosed with encephalitis <18 years of age admitted to 1 of the 8 pediatric intensive care units (PICU) in the Netherlands between January 2003 and December 2013. We analyzed demographic characteristics, clinical symptoms, neurologic imaging, etiology, treatment and mortality.
RESULTS
We included 121 children with a median age of 4.6 years (IQR 1.3-9.8). The most frequently described clinical features were headache (82.1%), decreased consciousness (79.8%) and seizures (69.8%). In 44.6% of the children, no causative agent was identified. Viral- and immune-mediated encephalitis were diagnosed in 33.1% and 10.7% of the patients. A herpes simplex virus infection (13.2%) was mainly seen in children <5 years of age, median age, 1.73 years (IQR 0.77-5.01), while immune-mediated encephalitis mostly affected older children, median age of 10.4 years (IQR, 3.72-14.18). An age of ≥ 5 years at initial presentation was associated with a lower mortality (OR 0.2 [CI 0.08-0.78]). The detection of a bacterial (OR 9.4 [CI 2.18-40.46]) or viral (OR 3.7 [CI 1.16-11.73]) pathogen was associated with a higher mortality.
CONCLUSIONS
In almost half of the Dutch children presenting with severe encephalitis, a causative pathogen could not be identified, underlining the need for enhancement of microbiologic diagnostics. The detection of a bacterial or viral pathogen was associated with a higher mortality.
Identifiants
pubmed: 32097245
doi: 10.1097/INF.0000000000002551
pmc: PMC7182237
pii: 00006454-202004000-00002
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
267-272Références
Pediatrics. 2010 Oct;126(4):e828-35
pubmed: 20876179
Semin Pediatr Neurol. 2014 Mar;21(1):26-9
pubmed: 24655401
Pediatrics. 2010 Feb;125(2):257-64
pubmed: 20064869
Neurology. 2007 Apr 17;68(16 Suppl 2):S23-36
pubmed: 17438235
Eur J Pediatr. 1997 Jul;156(7):541-5
pubmed: 9243237
Clin Neurophysiol. 2016 Oct;127(10):3217-24
pubmed: 27521622
Neurology. 2014 Feb 4;82(5):443-51
pubmed: 24384647
Lancet Infect Dis. 2010 Dec;10(12):835-44
pubmed: 20952256
Clin Neurol Neurosurg. 2017 Oct;161:110-116
pubmed: 28866263
Neuropsychol Rehabil. 2007 Aug-Oct;17(4-5):429-49
pubmed: 17676529
Lancet. 1989 Jan 7;1(8628):31-4
pubmed: 2563011
Euro Surveill. 2017 Apr 20;22(16):
pubmed: 28449731
J Clin Microbiol. 1997 Mar;35(3):691-6
pubmed: 9041414
J Child Neurol. 2005 Jun;20(6):500-8
pubmed: 15996399
Euro Surveill. 2008 Jan 17;13(3):
pubmed: 18445392
Pediatrics. 2015 Apr;135(4):e974-84
pubmed: 25802349
Lancet Infect Dis. 2017 Apr;17(4):422-430
pubmed: 28259562
Pediatrics. 2014 Mar;133(3):e546-52
pubmed: 24534397
BMC Infect Dis. 2017 Jul 14;17(1):494
pubmed: 28705180
Lancet Neurol. 2011 Jan;10(1):63-74
pubmed: 21163445
J Trop Pediatr. 2001 Aug;47(4):243-7
pubmed: 11523767
Pediatr Infect Dis J. 2013 Aug;32(8):839-44
pubmed: 23518823
Med Mal Infect. 2017 May;47(3):221-235
pubmed: 28341533
Can J Infect Dis Med Microbiol. 2015 Mar-Apr;26(2):69-72
pubmed: 26015788
Eur J Paediatr Neurol. 2008 Nov;12(6):484-90
pubmed: 18313340
J Pediatr Neurosci. 2009 Jan;4(1):20-4
pubmed: 21887170
Pediatr Neurol. 2015 Jul;53(1):3-12
pubmed: 25957806
Neuroradiology. 2015 Jan;57(1):55-62
pubmed: 25292353
Pediatrics. 2007 Feb;119(2):e399-407
pubmed: 17272602
Emerg Infect Dis. 2013;19(9):
pubmed: 23969035
Clin Infect Dis. 2008 Aug 1;47(3):303-27
pubmed: 18582201
Arch Dis Child. 2012 Feb;97(2):150-61
pubmed: 21715390
J Child Neurol. 2012 Nov;27(11):1460-9
pubmed: 22935553
Arch Dis Child. 2016 Jan;101(1):51-6
pubmed: 26475868
Dev Med Child Neurol. 2016 Nov;58(11):1108-1115
pubmed: 27422743